Published: 09-03-2022 08:43 | Updated: 09-03-2022 08:58

Current calls, week 10, 2022

Tips from KI Grants Office about current calls.

Swedish and Nordic calls

KID - Call for funding 2022

KID funding is a block grant for partial financing of doctoral education at KI and is intended to cover the doctoral student’s salaries.

An application for KID funding is submitted in two stages. First, a simplified version called a pre-application is submitted. If approved, the applicant is invited to submit a complete application. Both applications are assessed in competition with all other applications.

Closing date: 15 February – 17 March 23:00 hours. (for Stage 1: Pre-application) and 23 May – 15 June 14:00 hours. (for those selected to go on to Stage 2: Complete Application).

Further information

SSF individual grants for Ukrainian scientists, 2022

Ukrainska forskare som kommer till Sverige under 2022 kan nu söka bidrag för att bedriva sin forskning här. 30 miljoner kronor avsätts i utlysningen som vänder sig till ukrainska medborgare med en doktorsexamen. Forskaren måste anställas av ett svenskt universitet eller forskningsinstitut under projekttiden.

Olika anställningsformer är tillåtna, allt ifrån tillfälliga anställningar som postdoktor eller gästprofessor, till mer permanenta tjänster.

Forskaren kan maximalt ansöka om tre miljoner kronor och projektet kan pågå i upp till tre år. En avsiktsförklaring, ett ”Letter of Intent”, ska lämnas in av den svenska värdinstitutionen.

Closing date: Ansökan kan skickas in under hela 2022

Further information

Network grant: Swedish research links - Swedish Research Council

Support the development of long-term research cooperation between Swedish researchers and researchers from low- and lower middle-income countries. Grants are worth up to SEK 400,000 per year for between one and two years.

Closing date: 29 March 2022

Further information

Research project grant within natural and engineering sciences - Swedish Research Council

Enables researchers to formulate a research concept, method and implementation, to solve a specific research task within a limited period in the areas of natural and engineering sciences. Grants are worth between SEK 400,000 and SEK 1.3 million per year for between one and four years.

Closing date: 29 March 2022

Further information

Starting grant within natural and engineering sciences - Swedish Research Council

Aims to give junior researchers within natural and engineering sciences the opportunity to establish themselves as independent researchers in Sweden. Grants are worth between SEK 400,000 and SEK 1.3 million per year for four years.

Closing date: 29 March 2022

Further information

Consolidator grant within natural and engineering sciences - Swedish Research Council

Aims to give the most prominent junior researchers within natural and engineering sciences the opportunity to consolidate their research and broaden their activities as independent researchers. Grants are worth SEK 2 million per year for five years.

Closing date: 29 March 2022

Further information

Tyck till om Vetenskapsrådets webbplats och digitala tjänster

Further information

Starting grant - Swedish Society for Medical Research (SSMF)

SSMF’s Starting Grant (previously SSMF:s Stora Anslag) is intended to give promising young researchers the opportunity to establish themselves as independent researchers. The support is aimed at those with postdoctoral qualifications, and covers salaries and associated operating expenses for four years. The research can be carried out either on full-time basis or on half-time basis, in combination with half-time clinical practice, for medical practitioners who undertake research. 

Closing date: 15 April 2022

Further information

Consolidator grant - Swedish Society for Medical Research

The purpose of the grant is to give prominent researchers in medicine the opportunity to strengthen their position as independent researchers. The grant is worth SEK 11 million, including indirect costs, for five years. The grant can be used for research in all medical fields. SSMF supports basic research as well as applied research.

Closing date: 15 April 2022

Further information

Swedish Society for Rheumatology

  • UCB Pharma arthritis disease grant - Supports research on rheumatic diseases specifically arthritis diseases, preferably with a focus on spondylitis. Grant is worth SEK 100,000.
  • Amgen psoriatic arthritis research grant - Supports a project that promotes clinical rheumatology in Sweden and which includes arthritis research, preferably regarding psoriatic arthritis. The grant is worth SEK 50,000.
  • Galapagos Biopharma cellular mechanisms research grant - Supports research regarding cellular mechanisms in arthritis disease with significance for clinical outcome. The grant is worth SEK 100,000.
  • AstraZeneca systemic lupus erythematosus research grant - Supports research on biology or inflammation relevant to the understanding of the pathogenesis of systemic lupus erythematosus (SLE). The grant is worth SEK 100,000.

Closing date: 18 April 2022

Further information

European calls

Bob Pinedo cancer care award - Royal Netherlands Academy of Arts and Sciences (KNAW)

The Royal Netherlands Academy of Arts and Sciences (KNAW) invites nominations for the Bob Pinedo cancer care award. This recognises an internationally acclaimed researcher or research team currently active in the field of translational cancer research and compassionate cancer patient care.

Research institutes and individual researchers may nominate researchers and teams from anywhere in the world. Nominees must have an appointment at a research institute and the contributions for which they are nominated must have been made within the last 10 years.

Closing date: 1 May 2022

Further information

John Goldman award - European School of Haematology

The European School of Haematology invites applications for the John Goldman award. This supports a research project on treatment-free remissions in the field of haematology, minimal residual disease and other biomarkers of long-term remission or cure.

The grant is worth €80,000 for up to two years.

Closing date: 17 April 2022

Further information

Start-up grants - AO Foundation

The AO Foundation invites pre-proposals for its start-up grants. These support projects related to basic, preclinical and clinical research broadly in the fields of trauma and reconstruction in cranio-maxillofacial surgery. The aim is to provide predominantly seed money to researchers in the early part of their career.

Investigators who are members of AO CMF are eligible if they are 40 years of age or younger and are either: •within five years of the completion of their terminal degree, such as MD, Doctor of Veterinary Medicine or PhD; •within five years of initiation of their first assistant professor position at an academic institution; •enrolled in residency programmes or fellowships.

Closing date (pre-application): 25 March 2022

Further information

Bertelson award - European Society for Cognitive Psychology

The European Society for Cognitive Psychology invites nominations for the Bertelson award. This recognises a significant contribution to European cognitive psychology by a young scientist.

Candidates should normally have completed their doctoral thesis no more than eight years before nominations and be under 35 years of age.

Closing date: 1 May 2022

Further information

Junior research grant - International Headache Society

The International Headache Society invites applications for its junior research grant. This supports innovative and impactful research from young investigators, with the aim of promoting their careers in the field of headeache and increasing the knowledge base of headache disorders. Applications may be for basic or clinical headache research, or a combination of both.

Applicants must be a junior member of IHS and be the primary investigator of the proposed project.

The grant is worth €10,000 and lasts for two years.

Closing date: 12 May 2022

Further information

US calls

Federal Funding agencies

Noncoding RNAs in Alzheimer’s Disease and Related Dementias (R21 Clinical Trial Not Allowed), NIH

The goal of this Funding Opportunity Announcement (FOA) is to stimulate research in noncoding RNAs (ncRNAs) to investigate the causality, directionality, mechanisms, and therapeutic potential of ncRNAs in Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD).

  • The FOA (R01) supports applications seeking to discover novel mechanisms mediated by ncRNAs and to elucidate molecular and cellular functions involved in the pathogenesis and progression of AD/ADRD.
  • The FOA R21 supports exploratory and developmental grant applications seeking to discover functional roles of ncRNAs and underlying mechanisms involved in the pathogenesis and progression of AD/ADRD. Proposed studies should focus on functional characterization and mechanistic investigation of previously identified ncRNAs.

Closing date: July 15, 2022. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-AG-23-010 (R01); RFA-AG-23-011 (R21).

Further information (R01)

Further information (R21)

Integrating Mental Health Care into Health Care Systems in Low- and Middle-Income Countries (R01 Clinical Trial Optional), NIH

This Funding Opportunity Announcement (FOA) invites implementation research applications to develop, optimize, and test innovative theory-based strategies to integrate mental and physical health care within health care systems in low-and middle-income countries (LMICs). This FOA aims to support innovative research for implementing, scaling up, and financially sustaining integrated mental health care models to ultimately increase demand and utilization, quality, access, and availability of mental health care. This FOA is also expected to contribute to the long-term goals of strengthening the sustainable research capacity in LMICs and enhancing the potential for multidirectional knowledge and the exchange of research advancements. NIMH encourages partnerships between institutions in LMICs and high-income-countries (HICs).

Closing date: June 22, 2022. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-MH-22-130

Further information 

 

Foundations

Neuroimaging and cerebrospinal fluid biomarker development programme, Alzheimer’s Drug Discovery Foundation, US

The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer's disease and related dementias. This RFP prioritizes biomarkers with a defined context of use, a clear advantage over other relevant biomarkers, and a path to commercialization and/or clinical use.

Specifically, this RFP focuses on:

  • Developing novel PET ligands for clinical trials
  • Supporting novel CSF biomarkers
  • Validating innovative MRI approaches in larger cohorts
  • Developing novel measures of functional activity such as EEG

Novel biomarkers of neuroinflammation, synaptic integrity, autophagy and TDP-43 are high priority.

Closing date: May 20, 2022 (Letter of Intent), July 22, 2022 (Invited Full Proposal), and September 30, 2022 (Letter of Intent), December 2, 2022 (Invited Full Proposal). Must be received by 5:00 pm ET on the deadline date.


Further information 

Postdoctoral fellowship, Friedreich’s Ataxia Research Alliance, US

The Friedreich’s Ataxia Research Alliance invites letters of intent for its postdoctoral fellowship. This supports a postdoctoral trainee in the area of Friedreich’s ataxia. The PI may be either the trainee or the trainee’s faculty advisor, though both must be named in the application. Applicants must outline career and mentorship plans for the trainee, and provide a letter of reference from the faculty advisor.
Budget: The fellowship includes a trainee salary for up to two years. The anticipated direct costs budgeted must not exceed $100,000. FARA does not fund indirect costs.
Closing date: August 15, 2022 (Letter of Intent), October 15, 2022 (Full application).

Further information